Clincosm LogoSign in Get a demo

Lymphoma Follow-up

Sponsor
National Institute on Aging (NIA) (NIH)
Overall Status
Completed
CT.gov ID
NCT00744120
Collaborator
(none)
51
Enrollment
1
Location
119
Duration (Months)
0.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This follow-up protocol is designed to evaluate participants who have previously been lymphoma patients treated on approved clinical studies of the National Institutes of Health.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The intent of this protocol is to accrue up to 800 volunteers who are interested in participating in NIA research studies as part of follow-up for previous cancer treatment at NIH. Participants will be asked to answer questions regarding their general health status, diagnoses, and admissions to hospital, and to provide possible documentation. They may be asked to come to the NIA Clinical Research Unit at Harbor Hospital to participate in a follow-up evaluation. They will have the opportunity to obtain additional information about studies in which they may wish to participate and to discuss eligibility issues with NIA staff members. Any identified clinical problems in need of care will also be discussed. Volunteers may be referred, with their permission, to their private medical doctor for follow-up. They may be re-evaluated within a year for further follow-up.

    The follow-up evaluation may include history and physical, blood and urine tests, questionnaire, MRI or CT.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    51 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Lymphoma Follow-up Protocol
    Study Start Date :
    Oct 1, 2003
    Actual Primary Completion Date :
    Sep 1, 2013
    Actual Study Completion Date :
    Sep 1, 2013

    Outcome Measures

    Primary Outcome Measures

    1. Long-term survival following treatment for lymphoma [Annually]

    Secondary Outcome Measures

    1. Long-term toxicity possibly attributable to lymphoma or treatment for lymphoma [Annually]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • Previously treated on an approved NCI/NIH protocols

    • Willing and able to provide informed consent for current NIA protocol

    • Rare, unusual, interesting or unknown condition that requires diagnosis

    Exclusion Criteria:
    • Does not meet the criteria of any previously-approved NIH Protocol.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 NIA Clinical Research Unit Baltimore Maryland United States 21225

    Sponsors and Collaborators

    • National Institute on Aging (NIA)

    Investigators

    • Principal Investigator: Patricia L. Duffey, RN, National Institute on Aging (NIA)

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    National Institute on Aging (NIA)
    ClinicalTrials.gov Identifier:
    NCT00744120
    Other Study ID Numbers:
    • AG0108
    First Posted:
    Aug 29, 2008
    Last Update Posted:
    Dec 20, 2013
    Last Verified:
    Dec 1, 2013
    Keywords provided by National Institute on Aging (NIA)
    cancer
    Additional relevant MeSH terms:
    Lymphoma

    Study Results

    No Results Posted as of Dec 20, 2013